Healthcare-focused exchange-traded products saw “unprecedented” levels of new investment in April, as overall inflows for the global ETP sector reached $68.6 billion (€63.3 billion).
A recovery in risk sentiment was said to be the driver behind the flood of new cash, according to US fund house BlackRock, which published the figures.
At a sector level, investors allocated $7.3 billion to healthcare ETPs – the largest monthly inflow on record, beating the previous record set in November 2016 when Donald Trump was elected as US president.
There has been increasing focus on the healthcare sector amidst the current pandemic. “Attention on medical device production and pharmaceutical innovation has offered investors two rationales for investing in the sector,” BlackRock said in a statement.
US healthcare equity ETPs took the lion’s share of inflows, with $6.1 billion of new cash. European healthcare ETPs brought in $0.5 billion which, although a small figure by comparison, was a record in itself, according to the firm.
US equity ETPs overall saw their largest weekly inflows since September last year, attracting $17.7 billion at the start of April. These flows dropped off towards the end of the month, however, as investors de-risked leaving the net figure for the month set at $18.3 billion
Commodity ETP flows also benefitted from the increase in risk appetite, bringing in $21.4 billion, surpassing the previous monthly inflow record by almost $10 billion.
Inflows into both gold and crude oil ETPs hit new highs, with US and Asia-Pacific listed crude oil ETPs seeing the majority of new cash, according to the report. Gold ETPs added $9.2 billion in April, up from $7.7 billion in March.
A return to positive buying in fixed income offset the drop off in equity buying – which has been hit especially hard by the market volatility sparked by the Covid-19 pandemic.
Credit saw record inflows in April, following on from the positive momentum in the last two weeks of March, with high yield drawing in $8.4 billion, and investment grade attracting $13.3 billion of new cash.
Outflows continued from emerging markets equities – which have now been sold for eight out of the past 12 months – with investors pulling $9.8 billion from the sector.
“The outflows were across the board, in contrast to March, when buying in single country ETPs – particularly those exposed to Asia – offset selling out of broad EM equity products, leading to muted net outflows of $1.1B,” the report stated.
A reversal of sentiment led to led to flows out of China, Brazil and South Korean equity ETPs, while selling out of broad emerging market equity slowed but remained negative at $4.8 billion.
© 2020 funds global asia 
At times like these, HSBC Asset Management easily pivots towards emerging markets.
The spotlight on growth markets and the need to be nimble and dynamic is ever-sharper, given the difficulty in predicting monetary policy in the world’s major nations.
A comprehensive, cost-effective, and transparent currency overlay hedging solution is crucial to mitigate FX exposure risks in the complex landscapes of Japan and China's FX markets, explains Hans Jacob Feder, PhD, global head of FX services at MUFG Investor Services.
The world is transitioning from an era of commodity abundance to one of undersupply. Ben Ross and Tyler Rosenlicht of Cohen & Steers believe this shift may result in significant returns for commodities and resource producers over the next decade.
Ross Dilkes, fixed income portfolio manager at Wellington Management, examines the opportunities and risks for bond investors presented by the region’s decarbonisation agenda.
Shareholders in Japan no longer accept below-par corporate governance standards. Changes are taking place, but there are still areas for improvement, says Tetsuro Takase at SuMi Trust.
Robert St Clair, head of investment strategy at Fullerton Fund Management, explores the reasons investors should be paying attention to the rising demand for healthcare in China.
